Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Stock Jumped on Thursday

By Daniel Sparks – Updated Jul 30, 2020 at 2:21PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Virtual care adoption is soaring amid the COVID-19 pandemic.

What happened

Shares of Teladoc Health (TDOC -2.04%) jumped on Thursday, rising about 6% as of 1:40 p.m. EDT. The stock's gain came after the company announced second-quarter results.

Shares of the telehealth specialist were likely up because the company's quarterly revenue and management's guidance for its third-quarter revenue were both far higher than analysts were expecting. In addition, many analysts boosted their price targets for the growth stock after the report was released.

A chart showing a stock price rising

Image source: Getty Images.

So what

Teladoc reported a loss per share of $0.34 on revenue of $241 million. Analysts, on average, were expecting a loss per share of $0.23 and revenue of $221 million. 

The better-than-expected top line represented a major acceleration in the company's revenue growth rate. Total revenue was up 85% year over year, compared to 41% revenue growth in the first quarter of 2020. 

The telehealth platform provider is benefiting from a huge acceleration in the adoption of virtual care. Total visits were up 203% year over year during the quarter.

Showing how much the report impressed the Street, nine analysts have already lifted their 12-month price targets for the stock since the second-quarter update was released yesterday afternoon.

Now what

Management expects an even bigger third quarter. Teladoc guided for revenue during the period to be between $275 million and $285 million. Analysts, on average, were expecting third-quarter revenue of $217 million.

Capturing the company's significant momentum amid the coronavirus pandemic and the expected contribution of the company's recent acquisition of InTouch Health, the midpoint of Teladoc's third-quarter revenue guidance range implies 103% year-over-year growth.

Daniel Sparks has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$26.42 (-2.04%) $0.55

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.